Pharma Co. Wants Suit Over Underpaying Board Chair Axed
Altum Pharmaceuticals and its psychedelics-focused parent company asked a New York federal judge to permanently toss a $12 million suit accusing them of self-dealing and stock dilution and underpaying the executive...To view the full article, register now.
Already a subscriber? Click here to view full article